Our findings that an oral route of trehalose administration as well as inhibition of trehalase are ineffective in mitigating diet-induced obesity and metabolic disease should provide clarity for the field. The gene discussed is TREH; the disease is obesity due to melanocortin 4 receptor deficiency.